Timetable: Initial (Full) marketing authorisation application - ATMP
Submitted by Anonymous (not verified) on 11 July 2024 - 10:47
Timetable: Initial (Full) marketing authorisation application - ATMP
Annual activity report 2023
Submitted by Anonymous (not verified) on 11 July 2024 - 10:35
Annual activity report 2023
Cancer Medicines Forum: May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 May 2024, 13:00 (CEST) to 23 May 2024, 16:00 (CEST)
Submitted by Anonymous (not verified) on 11 July 2024 - 10:15
Cancer Medicines Forum: May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 May 2024, 13:00 (CEST) to 23 May 2024, 16:00 (CEST)
Standard operating procedure for evaluation of conflicts of interests of experts for involvement in Agency activities
Submitted by Anonymous (not verified) on 11 July 2024 - 9:54
Standard operating procedure for evaluation of conflicts of interests of experts for involvement in Agency activities
Meetings management procedures
Submitted by Anonymous (not verified) on 11 July 2024 - 9:50
Meetings management procedures
Standard operating procedure for arrangements for handling of conflicts of interests for European Medicines Agency scientific meetings
Submitted by Anonymous (not verified) on 11 July 2024 - 9:48
Standard operating procedure for arrangements for handling of conflicts of interests for European Medicines Agency scientific meetings
Presentation - European Shortages Monitoring Platform (ESMP) essentials and industry reporting requirements webinar
Submitted by Anonymous (not verified) on 10 July 2024 - 16:02
Presentation - European Shortages Monitoring Platform (ESMP) essentials and industry reporting requirements webinar
Scientific recommendations on classification of advanced therapy medicinal products
Submitted by Anonymous (not verified) on 10 July 2024 - 15:50
Scientific recommendations on classification of advanced therapy medicinal products
Scientific recommendations on classification of advanced therapy medicinal products
Submitted by Anonymous (not verified) on 10 July 2024 - 15:50
Scientific recommendations on classification of advanced therapy medicinal products
Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired
Submitted by Anonymous (not verified) on 10 July 2024 - 15:31
Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired